Grafting platelet-derived nanovesicles onto the surface of cardiosphere-derived cardiac stem cells enables the cells to better engraft in infarcted tissue following systemic injection in rats and pigs.
This is a preview of subscription content, log in via an institution to check access.
References
Fisher, S. A. et al. Clin. Pharmacol. Ther. 100, 88–101 (2016).
Contreras, A. et al. Basic Res. Cardiol. 112, 3 (2017).
Wollert, K. C. et al. Eur. Heart J. 38, 2936–2943 (2017).
Puymirat, E. et al. Circulation 136, 1908–1919 (2017).
Hofmann, M. et al. Circulation 111, 2198–2202 (2005).
Tang, J. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-017-0182-x (2018).
Makkar, R. R. et al. Lancet 379, 895–904 (2012).
Lipinski, M. J. et al. Cardiovasc. Revasc. Med. 17, 106–112 (2016).
Lane, R. E. et al. Sci. Rep. 5, 7639 (2015).
Guo, Y. et al. Basic Res. Cardiol. 112, 18 (2017).
Jain, V. et al. Curr. Drug Deliv. 12, 177–191 (2015).
Liu, M. et al. Biomaterials 35, 3697–3707 (2014).
Yu, J. et al. J. Cell Mol. Med. 19, 1483–1491 (2015).
Kean, T. J. et al. J. Drug Target. 20, 23–32 (2012).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Menasché, P. Platelet vesicles help cardiac stem cells engraft. Nat Biomed Eng 2, 4–5 (2018). https://doi.org/10.1038/s41551-017-0185-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41551-017-0185-7
- Springer Nature Limited